The brain is particularly vulnerable to oxygen free radicals, and these radicals have been implicated in the pathology of several neurological disorders. In this study, the modulation of TNF-related apoptosis-inducing ligand (TRAIL) expression by oxidative stress was shown in LN215 cells, an astroglioma cell line. Hydrogen peroxide (H2O2) treatment increased TRAIL expression in LN215 cells and H2O2-induced TRAIL augmented apoptosis in Peer cells, a cell line sensitive to TRAILmediated cell death. Our findings suggest that the upregulation of TRAIL in astroglial cells may abrogate immune cell effector functions.
INTRODUCTION
TNF-related apoptosis-inducing ligand (TRAIL), a member of death ligand/receptor pairs, acts independently of Fas-mediated apoptosis. Like FasL, TRAIL induces rapid apoptosis in transformed cell lines of diverse origins. 1, 2 Death receptors (DR) 4 and DR5, which are receptors for TRAIL, mediate apoptosis by recruiting Fas-associated death domain (FADD) indirectly via the TNF receptor-associated death domain (TRADD) and by the subsequent activation of capsase 8. 3, 4 TRAIL and DR4 are expressed in many human tissues, including the spleen, lung, and prostate. 5 The human TRAIL promoter was cloned, and a number of transcription factor binding sites were identified, namely, the NFAT, AP-1, and Sp1 sequences, which are important for the expression of other TNF family members. 6 DR4 and DR5
were expressed in normal brain tissue and glioma. 7 Although TRAIL expression is detected in many human tissues, TRAIL is not always cytotoxic due to the presence of decoy receptors. The decoy receptors, DcR1 and DcR2, have also been found in many types of normal cells. whereas many tumor cell lines do not express DcR1, 2, 5 which abrogates apoptotic signals by binding TRAIL, because DcR1 does not have death domains. DcR2 has a truncated form of cytoplasmic tail, which cannot transduce cell death signals. 8 The relationship between reactive oxygen intermediate (ROIs) products and central nervous system (CNS) tumors is a current and important topic in light of their involvement in pathological conditions and possible therapeutic interventions. Hydrogen peroxide (H 2 O 2 ) has been implicated in cellular and tissue injury during pathologic conditions, such as ischemia-reperfusion injury, hyperoxia, and inflammation. 9 In addition, the stimulation of various cells with either cytokines or phorbol ester increases the secretion of H2O2 into the extracellular space in vitro. 10, 11 High concentrations of this diffusible ROI exert toxic effects on susceptible cells. However, low concentrations of H 2 O 2 alter cellular functions by modulating signal transduction in certain cells, including endothelial cells. 12 Oxidative injury occurs in various ways and has been studied in several diverse models, using different eliciting agents and biological preparations. The common feature of these models is that the primary activation involves radical formation; those radicals and related products then generate a potent oxidant, which subsequently inactivates macromolecules. ROI-mediated damage has been generally associated with necrosis; however, some observations suggest that it has a role in apoptosis. 13 
MATERIALS AND METHODS

Culture
RT-PCR and RNase protection assay (RPA)
RT-PCR was performed using the following primer sets: TRAIL primers (forward: 5'-CCC AAT gAC gAA gAg AgT ATg A -3'; reverse: 5'-ggA ATA gAT gTA gTA AAA CCC T-3. PCR conditions were as follows: denaturation at 94 for 30s, annealing at 55 for 30s, and extension at 72 for 30s for TRAIL. The buffer used for PCR was 10 mM Tris-HCl (pH 10), 2.0 mM MgCl 2 , 50 mM KCl with 1.25 U of Taq polymerase (Takara, Tokyo, Japan). After 27 cycles, an additional extension at 72 for 10 min was carried out.
To detect TRAIL expressions, an RNase protection assay was done using the RiboQuant multiprobe RNase protection assay system (Pharmingen, San Diego, CA, USA). Briefly, 15 g of total RNA μ was hybridized overnight with the in vitro-translated 32 P-labeled RNA probe; hAPO-3C kit and samples were treated with RNase A and proteinase.
Western blot
A total of 1 × 10 6 LN215 cells were used for protein purification. Protein was extracted by ultrasonication and centrifuged to remove cell debris. The resulting supernatant was quantified using the Bradford method (Pierce, Rockford, IL, USA). Protein (50 g) was then loaded onto 12% μ Tris-HCL SDS-polyacrylamide gel (BioRad, Hercules, CA, USA), and transferred to a nitrocellulose transfer membrane (Amersham Pharmacia Biotech, Piscataway, NJ, USA). TRAIL expression was determined using anti-TRAIL monoclonal Ab (Pharmingen) diluted 1:500 and anti-mouse rabbit Ab (Jackson Immuno Research, Baltimore, MD, USA) was used as a secondary Ab. Proteins were visualized using the ECL technique (Amersham Pharmacia Biotech.). 
Flow cytometry analysis
RESULTS
The expression of TRAIL in human astroglial cells treated with H2O2
We hypothesized treatment with H2O2 would modulate the apoptosis-related gene expression of astroglial cells in central nerve system. To address this, human LN215 astroglioma cells were treated with H2O2 and the expression of TRAIL was detected by RT-PCR, RPA, western blot and flow cytometry.
We experimented to determine whether treatment with H2O2 induced TRAIL expression in human astroglial cells. LN215 cells were treated with varying concentrations of H 2 O 2 (0-800 M) μ for 4 hrs (for mRNA) or 18 hrs (for protein). H2O2-mediated TRAIL induction was observed by RT-PCR (Fig. 1A) and western blot (Fig 2A) . TRAIL expression was induced treatment of H2O2 and reached maximum expression at 800 M of H μ 2O2 (Fig. 1A, 2A ). LN215 cells were treated with 800 M of H μ 2O2 for various times (0 -24 hrs). The time course of the TRAIL expression was then determined by RPA (Fig. 1B) or western blot (Fig 2C) . The gene expression of TRAIL was induced at 1 h and continued until 24 hrs (Fig. 1B) . TRAIL protein expression reached its maximum at 8 hrs and continued until 24 hrs (Fig. 2C) . Also H2O2-mediated TRAIL induction was observed by flow cytometry (Fig. 2B) .
Inhibition of TRAIL expression by cyclosporin A in human astroglial cells treated with H 2 O 2
Cyclosporin A (CsA), an immunosuppressive drug that targets calcineurin, blocked both RNA and protein expression of TRAIL in LN215 cells after treatment with H2O2 (Fig. 3A, 3B) . The most effective concentration of CsA started at 100 ng/ mL. To address the biological function of TRAIL in LN215 cells after H2O2 treatment, LN215 cells were co-cultured with Peer cells, a cell line sensitive to TRAIL mediated apoptosis. Annexin V staining of Peer cells showed an increase in apoptotic cells after H2O2 treatment, 64.2% versus 47.5% in the control group (Fig. 4) . Peer cells treated with both CsA and H2O2 inhibited TRAIL induced apoptosis down to 49.8%, a level similar to control (Fig. 4) .
DISCUSSION
Our study demonstrates that oxidative stress modulates the expression of TRAIL, which is involved in apoptosis. The up-regulation of FasL and Fas by IFN-or TNF-has been reported in γ α primary astrocytes, 20 is known to be a potent activator of NF-B. Moreover, the CD95L promoter has been κ described to contain NF-B binding sites, which κ suggests that NF-B may regulate FasL expres κ sion. In contrast to the limited expression of FasL, TRAIL mRNA has been detected in nearly all tissues. However, malignant astoroglioma cells express both TRAIL mRNA and protein. 22, 23 In our study, TRAIL was detected constitutively in LN 215 cells, an astroglioma cell line, and its expression was increased by H2O2. In this study, CsA, a pharmacological inhibitor of the phosphatase calcineurin, blocked TRAIL expression at concentrations between 100 and 10 g/mL. These concentrations are reported to be μ nontoxic to primary rat astrocytes, 24 suggesting that NFAT might be involved in TRAIL expression in human astrocytes. NFAT is known to be expressed in T cells and other immune cells.
However, several data show that cells of the nervous system, such as a neuronal cell line and rat astrocytes, express NFAT. 24, 25 Moreover, the CsAsensitive signaling pathway has been reported to regulate the survival of reactive astrocytes. 24 Involvement of ROS in NFAT has been demonstrated in T cells. 27, 28 Also, 1.6 kb of the human TRAIL promoter was identified to have binding sites for such factors as NFAT, AP-1, and Sp1. 6 Therefore, NFAT, under conditions of oxidative stress, may act as a transcription factor, signaling induction of TRAIL. Although H2O2 has been known to activate NF-B, κ 29, 30 it is not certain whether the expression of TRAIL and its receptors is regulated by H2O2-activated NF-B. Although κ basal ROI in tumors can be lower than in normal brain tissue, 31 it is important to keep in mind the effects of drug-induced apoptosis on tumor cells by ROI-producing chemotherapies. 32 In our study, the upregulation of TRAIL suggests that some astroglial cells up-regulate TRAIL and may abrogate lymphocytes or other immune cells, thereby escaping immune surveillance. Further investigations into the regulation of TRAIL and TRAIL receptors are necessary to answer critical questions related to whether a specific gain of decoy receptors and death receptors in astroglioma cells, as compared with non-neoplastic cells allows the selective therapeutic elimination of tumor cells in vivo.
Collectively our findings suggest that TRAIL may be inducible by hypoxia and other forms of oxidative stress, such as tumor-associated hypoxia or chemotherapy-induced hypoxia. Therefore, oxidative stress leading to the upregulation of TRAIL presumably plays an apoptotic role in pathological conditions of the brain.
